Related Experiment Video
Updated: Nov 25, 2025
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
2.0K
Percutaneous Versus Surgical Revascularization for Acute Myocardial Infarction.
Tariq Enezate1, Kristina Gifft2, Cliff Chen2
1Division of Cardiology, UCLA-Harbor Medical Center, Los Angeles, CA, USA.
Summary
Percutaneous revascularization (PR) after acute myocardial infarction (AMI) shows higher mortality but lower morbidity and costs than surgical revascularization (SR). SR offers a survival benefit only in multivessel cases, not single-vessel revascularization.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Acute myocardial infarction (AMI) necessitates timely revascularization.
- Percutaneous revascularization (PR) is a common first-line treatment for AMI.
- Limited comparative data exists for PR versus surgical revascularization (SR) in AMI.
Purpose of the Study:
- To compare in-hospital outcomes of PR versus SR in patients with AMI.
- To evaluate mortality, morbidity, length of stay, and hospital charges associated with each revascularization strategy.
Main Methods:
- Analysis of the 2016 Nationwide Readmissions Data.
- Inclusion of patients with AMI undergoing either PR or SR.
- Endpoints included in-hospital mortality, length of stay, stroke, acute kidney injury, bleeding, transfusion, respiratory failure, and total charges.
Main Results:
- PR was associated with higher in-hospital mortality (3.7% vs 2.2%) but lower morbidity, shorter LOS (4.3 vs 11.6 days), and lower charges ($120,590 vs $229,917) compared to SR.
- SR showed a mortality benefit in multivessel revascularization but not in single-vessel revascularization.
- PR was more common (79.1%) than SR (20.9%) for AMI.
Conclusions:
- PR in AMI patients leads to higher mortality but reduced morbidity, shorter hospital stays, and lower costs than SR.
- SR demonstrates a survival advantage exclusively in multivessel revascularization cases.
- The choice between PR and SR in AMI should consider the extent of coronary artery disease.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
313
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
313
01:28Acute Coronary Syndrome IV: Interprofessional Care
98
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
98
01:27Coronary Artery Disease V: Interprofessional Care
129
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
129